Risk of Selected Birth Defects with Prenatal Illicit Drug Use, Hawaii, 1986–2002

REFERENCES

• Abe, K., Honein, M. A., and Moore, C. A., 2003. Maternal febrile illnesses, medication use, and the risk of congenital renal anomalies, Birth Defects Res. A Clin. Mol. Teratol 67 (2003), pp. 911–918.
   PubMedGoogle Scholar
• Adams, M. M., Mulinare, J., and Dooley, K., 1989. Risk factors for conotruncal cardiac defects in Atlanta, J. Am. Coll. Cardiol 14 (1989), pp. 432–442.
   PubMed Web of Science ®Google Scholar
• Battin, M., Albersheim, S., and Newman, D., 1995. Congenital genitourinary tract abnormalities following cocaine exposure in utero, Am. J. Perinatol 12 (1995), pp. 425–428.
   PubMed Web of Science ®Google Scholar
• Beaty, T. H., Wang, H., Hetmanski, J. B., Fan, Y. T., Zeiger, J. S., Liang, K. Y., Chiu, Y. F., Vanderkolk, C. A., Seifert, K. C., Wulfsberg, E. A., Raymond, G., Panny, S. R., and McIntosh, I., 2001. A case-control study of nonsyndromic oral clefts in Maryland, Ann. Epidemiol 11 (2001), pp. 434–442.
   PubMed Web of Science ®Google Scholar
• Behnke, M., Eyler, F. D., Garvan, C. W., and Wobie, K., 2001. The search for congenital malformations in newborns with fetal cocaine exposure, Pediatrics 107 (2001).
   PubMed Web of Science ®Google Scholar
• Carmichael, S. L., Shaw, G. M., and Nelson, V., 2002. Timing of prenatal care initiation and risk of congenital malformations, Teratology 66 (2002), pp. 326–330.
   PubMedGoogle Scholar
• Chouteau, M., Namerow, P. B., and Leppert, P., 1988. The effect of cocaine abuse on birth weight and gestational age, Obstet. Gynecol 72 (1988), pp. 351–354.
   PubMed Web of Science ®Google Scholar
• Christmas, J. T., Knisely, J. S., Dawson, K. S., Dinsmoor, M. J., Weber, S. E., and Schnoll, S. H., 1992. Comparison of questionnaire screening and urine toxicology for detection of pregnancy complicated by substance use, Obstet. Gynecol 80 (1992), pp. 750–754.
   PubMed Web of Science ®Google Scholar
• Correa-Villasenor, A., Ferencz, C., Neill, C. A., Wilson, P. D., and Boughman, J. A., 1994. Ebstein’s malformation of the tricuspid valve: Genetic and environmental factors. The Baltimore-Washington Infant Study Group, Teratology 50 (1994), pp. 137–147.
   PubMedGoogle Scholar
• Cosden, M., Peerson, S., and Elliott, K., 1997. Effects of prenatal drug exposure on birth outcomes and early child development, J. Drug Issues 27 (1997), pp. 525–539.
   Web of Science ®Google Scholar
• Croen, L. A., Shaw, G. M., and Lammer, E. J., 2000. Risk factors for cytogenetically normal holoprosencephaly in California: A population-based case-control study, Am. J. Med. Genet 90 (2000), pp. 320–325.
   PubMed Web of Science ®Google Scholar
• Derauf, C., Katz, A. R., Frank, D. A., Grandinetti, A., and Easa, D., 2003. The prevalence of methamphetamine and other drug use during pregnancy in Hawaii, J. Drug Issues 33 (2003), pp. 1001–1016.
   Web of Science ®Google Scholar
• de Vries, P. A., 1980. The pathenogenesis of gastroschisis and omphalocele, J. Pediatr. Surg 15 (1980), pp. 245–251.
   PubMed Web of Science ®Google Scholar
• Ferencz, C., Loffredo, C. A., Correa-Villasenor, A., and Wilson, P. D., 1997a. "Defects of laterality and looping". In: Genetic and environmental risk factors of major cardiovascular malformations: The Baltimore–Washington Infant Study: 1981–1989. Armonk, NY: Futura; 1997a. pp. 41–57.
   Google Scholar
• Ferencz, C., Loffredo, C. A., Correa-Villasenor, A., and Wilson, P. D., 1997b. "Atriventricular septal defects with and without Down syndrome". In: Genetic and environmental risk factors of major cardiovascular malformations: The Baltimore–Washington Infant Study: 1981–1989. Armonk, NY: Futura; 1997b. pp. 103–122.
   Google Scholar
• Ferencz, C., Loffredo, C. A., Correa-Villasenor, A., and Wilson, P. D., 1997c. "Ventricular septal defects". In: Genetic and environmental risk factors of major cardiovascular malformations: The Baltimore–Washington Infant Study: 1981–1989. Armonk, NY: Futura; 1997c. pp. 123–163.
   Google Scholar
• Ferencz, C., Loffredo, C. A., Correa-Villasenor, A., and Wilson, P. D., 1997d. "Tricuspid atresia with normally related great arteries". In: Genetic and environmental risk factors of major cardiovascular malformations: The Baltimore–Washington Infant Study: 1981–1989. Armonk, NY: Futura; 1997d. pp. 258–265.
   Google Scholar
• Ferencz, C., Loffredo, C. A., Correa-Villasenor, A., and Wilson, P. D., 1997e. "Ebstein’s malformation of the tricuspid valve". In: Genetic and environmental risk factors of major cardiovascular malformations: The Baltimore–Washington Infant Study: 1981–1989. Armonk, NY: Futura; 1997e. pp. 325–334.
   Google Scholar
• Forrester, M. B., and Merz, R. D., 2004. Descriptive epidemiology of selected congenital heart defects, Hawaii, 1986–1999, Paediatr. Perinat. Epidemiol 18 (2004), pp. 415–442.
   PubMed Web of Science ®Google Scholar
• Forrester, M. B., and Merz, R. D., 2005. Rates of selected birth defects in relation to folic acid fortification, 1986–2002, Hawaii Med. J 64 (2005), pp. 300–305.
   PubMedGoogle Scholar
• Forrester, M. B., Merz, R. D., and Yoon, P. W., 1998. Impact of prenatal diagnosis and elective termination on the prevalence of selected birth defects in Hawaii, Am. J. Epidemiol 148 (1998), pp. 1206–1211.
   PubMed Web of Science ®Google Scholar
• Frey, L., and Hauser, W. A., 2003. Epidemiology of neural tube defects, Epilepsia 44 (suppl. 3) (2003), pp. 4–13.
   PubMed Web of Science ®Google Scholar
• Gardner, J. S., Guyard-Boileau, B., Alderman, B. W., Fernbach, S. K., Greene, C., and Mangione, E. J., 1998. Maternal exposure to prescription and nonprescription pharmaceuticals or drugs of abuse and risk of craniosynostosis, Int. J. Epidemiol 27 (1998), pp. 64–67.
   PubMed Web of Science ®Google Scholar
• Holzman, C., and Paneth, N., 1994. Maternal cocaine use during pregnancy and perinatal outcomes, Epidemiol. Rev 16 (1994), pp. 315–334.
   PubMed Web of Science ®Google Scholar
• Honein, M. A., Paulozzi, L. J., and Watkins, M. L., 2001. Maternal smoking and birth defects: Validity of birth certificate data for effect estimation, Public Health Rep 116 (2001), pp. 327–335.
   PubMed Web of Science ®Google Scholar
• Hoyme, H. E., Jones, M. C., and Jones, K. L., 1983. Gastroschisis: Abdominal wall disruption secondary to early gestational interruption of the omphalomesenteric artery, Semin. Perinatol 7 (1983), pp. 294–298, .
   PubMed Web of Science ®Google Scholar
• Hume, R. F., Martin, L. S., Bottoms, S. F., Hassan, S. S., Banker-Collins, K., Tomlinson, M., Johnson, M. P., and Evans, M. I., 1997. Vascular disruption birth defects and history of prenatal cocaine exposure: A case control study, Fetal Diagn. Ther 12 (1997), pp. 292–295.
   PubMed Web of Science ®Google Scholar
• Hussain, N., Chaghtai, A., Herndon, A., Herson, V. C., Rosenkrantz, T. S., and McKenna, P. H., 2002. Hypospadias and early gestation growth restriction in infants, Pediatrics 109 (2002), pp. 473–478.
   PubMed Web of Science ®Google Scholar
• Hutchins, E., 1997. Drug use during pregnancy, J. Drug Issues 27 (1997), pp. 463–485.
   Web of Science ®Google Scholar
• Kuehl, K. S., and Loffredo, C., 2002. Risk factors for heart disease associated with abnormal sidedness, Teratology 66 (2002), pp. 242–248.
   PubMedGoogle Scholar
• Leiken, J. B., and Paloucek, F. P., 1998. Poison and toxicology compendium with symptoms index. Hudson, OH: Lexi-Corp, Inc; 1998.
   Google Scholar
• Li, D. K., Daling, J. R., Mueller, B. A., Hickok, D. E., Fantel, A. G., and Weiss, N. S., 1995. Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies, Epidemiology 6 (1995), pp. 212–218.
   PubMed Web of Science ®Google Scholar
• Lipshultz, S. E., Frassica, J. J., and Orav, E. J., 1991. Cardiovascular abnormalities in infants prenatally exposed to cocaine, J. Pediatr 118 (1991), pp. 44–51.
   PubMed Web of Science ®Google Scholar
• Little, B. B., Snell, L. M., and Gilstrap, L. C., 1988. Methamphetamine abuse during pregnancy: Outcome and fetal effects, Obstet. Gynecol 72 (1988), pp. 541–544.
   PubMed Web of Science ®Google Scholar
• Luehr, B., Lipsett, J., and Quinlivan, J. A., 2002. Limb-body wall complex: A case series, J. Matern. Fetal Neonatal Med 12 (2002), pp. 132–137.
   PubMedGoogle Scholar
• Makri, A., Goveia, M., Balbus, J., and Parkin, R., 2004. Children’s susceptibility to chemicals: A review by developmental stage, J. Toxicol. Environ. Health B Crit. Rev 7 (2004), pp. 417–435.
   PubMed Web of Science ®Google Scholar
• Martin, M. L., and Edmonds, L. D., 1991. Use of birth defects monitoring programs for assessing the effects of maternal substance abuse on pregnancy outcomes, N.I.D.A. Res. Monogr 114 (1991), pp. 66–83.
   PubMedGoogle Scholar
• Martin, M. L., and Khoury, M. J., 1992. Cocaine and single ventricle: A population study, Teratology 46 (1992), pp. 267–270.
   PubMedGoogle Scholar
• Martin, M. L., Khoury, M. J., Cordero, J. F., and Waters, G. D., 1992. Trends in rates of multiple vascular disruption defects, Atlanta, 1968–1989: Is there evidence of a cocaine teratogenic epidemic?, Teratology 45 (1992), pp. 647–653.
   PubMedGoogle Scholar
• Martinez-Frias, M. L., Bermejo, E., Rodriguez-Pinilla, E., and Frias, J. L., 2004. Risk for congenital anomalies associated with different sporadic and daily doses of alcohol consumption during pregnancy: A case-control study, Birth Defects Res. A Clin. Mol. Teratol 70 (2004), pp. 194–200.
   PubMed Web of Science ®Google Scholar
• McElhatton, P. R., Pughe, K. R., Evans, C., Porter, K., Bateman, D. N., and Thomas, S. H., 2000. Is exposure to amphetamine-like drugs in pregnancy associated with malformations?, J. Toxicol. Clin. Toxicol 38 (2000), pp. 195–196.
   Google Scholar
• National Birth Defects Prevention Network, 2004. State birth defects surveillance program directory, Birth Defects Res. A Clin. Mol. Teratol 70 (2004), pp. 609–676.
   Google Scholar
• Norton-Hawk, M. A., 1997. Frequency of prenatal drug abuse: Assessment, obstacles, and policy implications, J. Drug Issues 27 (1997), pp. 447–462.
   Web of Science ®Google Scholar
• Ostrea, E. M., Brady, M., Gause, S., Raymundo, A. L., and Stevens, M., 1992. Drug screening of newborns by meconium analysis: A large-scale, prospective, epidemiologic study, Pediatrics 89 (1992), pp. 107–113.
   PubMed Web of Science ®Google Scholar
• Penman, D. G., Fisher, R. M., Noblett, H. R., and Soothill, P. W., 1998. Increase in incidence of gastroschisis in the south west of England in 1995, Br. J. Obstet. Gynaecol 105 (1998), pp. 328–331.
   PubMedGoogle Scholar
• Sadler, T. W., 2000. Susceptible periods during embryogenesis of the heart and endocrine glands, Environ. Health Perspect 108 (suppl. 3) (2000), pp. 555–561.
   PubMed Web of Science ®Google Scholar
• Scholl, T. O., and Johnson, W. G., 2000. Folic acid: influence on the outcome of pregnancy, Am. J. Clin. Nutr 71 (suppl. 5) (2000), pp. 1295–1303.
   PubMed Web of Science ®Google Scholar
• Shaw, G. M., Velie, E. M., and Morland, K. B., 1996. Parental recreational drug use and risk for neural tube defects, Am. J. Epidemiol 144 (1996), pp. 1155–1160.
   PubMed Web of Science ®Google Scholar
• Steinberger, E. K., Ferencz, C., and Loffredo, C. A., 2002. Infants with single ventricle: A population-based epidemiological study, Teratology 65 (2002), pp. 106–115.
   PubMedGoogle Scholar
• Torfs, C. P., Velie, E. M., Oechsli, F. W., Bateson, T. F., and Curry, C. J., 1994. A population-based study of gastroschisis: Demographic, pregnancy, and lifestyle risk factors, Teratology 50 (1994), pp. 44–53.
   PubMedGoogle Scholar
• Werler, M. M., Lammer, E. J., Rosenberg, L., and Mitchell, A. A., 1990. Maternal vitamin A supplementation in relation to selected birth defects, Teratology 42 (1990), pp. 497–503.
   PubMedGoogle Scholar
• Williams, L. J., Correa, A., and Rasmussen, S., 2004. Maternal lifestyle factors and risk for ventricular septal defects, Birth Defects Res. A Clin. Mol. Teratol 70 (2004), pp. 59–64.
   PubMed Web of Science ®Google Scholar